Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
May act as a protease inhibitor to modulate the host immune response against tumor cells.. Additionally we are shipping Squamous Cell Carcinoma Antigen 1 Kits (19) and Squamous Cell Carcinoma Antigen 1 Proteins (2) and many more products for this protein.
Showing 3 out of 3 products:
A close connection between SerpinB3 (show SERPINB3 Antibodies) and DPPPIV has been identified, but further studies are required to better understand the mechanism by which these proteins communicate and exert metabolic effects in hepatocellular carcinoma.
Findings point to potential interest of squamous cell carcinoma antigen SERPINB3 (show SERPINB3 Antibodies)/B4 for the stratification of head and neck squamous cell carcinoma (HNSCC) patients in the therapeutic context.
role of SERPINB3 (show SERPINB3 Antibodies)/B4 mutations in immunotherapy response
Data show that in colorectal cancer SerpinB3 (show SERPINB3 Antibodies), COX-2 (show COX2 Antibodies) and beta-Catenin (show CTNNB1 Antibodies) are positively correlated and associated with more advanced tumor stage.
Results showed no correlation between gestational age and vaginal fluid SCC (show CYP11A1 Antibodies) levels. There was no significant difference in vaginal fluid SCC (show CYP11A1 Antibodies) levels between patients with premature rupture of membranes and those with control pregnant women.
Serum SCC (show CYP11A1 Antibodies)-Ag level was an important predictor for the cervical squamous carcinoma recurrence and prognosis.
Data indicate that serum tumor markers showed significant shorter 3-year progression-free survival (PFS) in higher levels compared to lower levels for S-CYFRA 21-1 (cytokeratin 19 (show KRT19 Antibodies) fragment), S-SCCA and S-CEA (show CEACAM5 Antibodies).
SerpinB3 (show SERPINB3 Antibodies) indirectly increased the transcription of Myc (show MYC Antibodies) through the induction of Yap (show YAP1 Antibodies) pathway.
Data show that serum neuron-specific enolase (show ENO2 Antibodies), cytokeratin 19 (show KRT19 Antibodies) fragment 21-1, pro-gastrin-releasing peptide (show GRP Antibodies), squamous cell carcinoma antigen, tissue inhibitor of metalloproteinase-1, and human epididymis protein 4 are not associated with brain metastases.
The diagnostic performance of SCCA-IgM immune complexes for hepatocellular carcinoma was found to be frequently superior to that of alpha-fetoprotein (show AFP Antibodies). (Review)
May act as a protease inhibitor to modulate the host immune response against tumor cells.
, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 3
, serpin B3
, squamous cell carcinoma antigen 1